These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 37108374

  • 1. miR-18a and miR-106a Signatures in Plasma Small EVs Are Promising Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma.
    Xu X, Bhandari K, Xu C, Morris K, Ding WQ.
    Int J Mol Sci; 2023 Apr 13; 24(8):. PubMed ID: 37108374
    [Abstract] [Full Text] [Related]

  • 2. Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma.
    Nesteruk K, Levink IJM, de Vries E, Visser IJ, Peppelenbosch MP, Cahen DL, Fuhler GM, Bruno MJ.
    Pancreatology; 2022 Jun 13; 22(5):626-635. PubMed ID: 35613957
    [Abstract] [Full Text] [Related]

  • 3. Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma.
    Liu DSK, Puik JR, Patel BY, Venø MT, Vahabi M, Prado MM, Webber JP, Rees E, Upton FM, Bennett K, Blaker C, Immordino B, Comandatore A, Morelli L, Sivakumar S, Swijnenburg RJ, Besselink MG, Jiao LR, Kazemier G, Giovannetti E, Krell J, Frampton AE.
    J Exp Clin Cancer Res; 2024 Jul 08; 43(1):189. PubMed ID: 38978141
    [Abstract] [Full Text] [Related]

  • 4. Small RNA sequencing analysis of peptide-affinity isolated plasma extracellular vesicles distinguishes pancreatic cancer patients from non-affected individuals.
    Roy JW, Wajnberg G, Ouellette A, Boucher JE, Lacroix J, Chacko S, Ghosh A, Ouellette RJ, Lewis SM.
    Sci Rep; 2023 Jun 07; 13(1):9251. PubMed ID: 37286718
    [Abstract] [Full Text] [Related]

  • 5. Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Guo S, Qin H, Liu K, Wang H, Bai S, Liu S, Shao Z, Zhang Y, Song B, Xu X, Shen J, Zeng P, Shi X, Chen H, Gao S, Xu J, Pan Y, Xiong L, Li F, Zhang D, Jiao X, Jin G.
    Clin Transl Med; 2021 Sep 07; 11(9):e520. PubMed ID: 34586739
    [Abstract] [Full Text] [Related]

  • 6. Shared extracellular vesicle miRNA profiles of matched ductal pancreatic adenocarcinoma organoids and blood plasma samples show the power of organoid technology.
    Zeöld A, Sándor GO, Kiss A, Soós AÁ, Tölgyes T, Bursics A, Szűcs Á, Harsányi L, Kittel Á, Gézsi A, Buzás EI, Wiener Z.
    Cell Mol Life Sci; 2021 Mar 07; 78(6):3005-3020. PubMed ID: 33237353
    [Abstract] [Full Text] [Related]

  • 7. Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma.
    Han Y, Drobisch P, Krüger A, William D, Grützmann K, Böthig L, Polster H, Seifert L, Seifert AM, Distler M, Pecqueux M, Riediger C, Plodeck V, Nebelung H, Weber GF, Pilarsky C, Kahlert U, Hinz U, Roth S, Hackert T, Weitz J, Wong FC, Kahlert C.
    J Hematol Oncol; 2023 Feb 03; 16(1):7. PubMed ID: 36737824
    [Abstract] [Full Text] [Related]

  • 8. miR-365 secreted from M2 Macrophage-derived extracellular vesicles promotes pancreatic ductal adenocarcinoma progression through the BTG2/FAK/AKT axis.
    Li X, Xu H, Yi J, Dong C, Zhang H, Wang Z, Miao L, Zhou W.
    J Cell Mol Med; 2021 May 03; 25(10):4671-4683. PubMed ID: 33811437
    [Abstract] [Full Text] [Related]

  • 9. Isolation of extra-cellular vesicles in the context of pancreatic adenocarcinomas: Addition of one stringent filtration step improves recovery of specific microRNAs.
    Xu YF, Xu X, Bhandari K, Gin A, Rao CV, Morris KT, Hannafon BN, Ding WQ.
    PLoS One; 2021 May 03; 16(11):e0259563. PubMed ID: 34784377
    [Abstract] [Full Text] [Related]

  • 10. Circulating cancer-associated extracellular vesicles as early detection and recurrence biomarkers for pancreatic cancer.
    Yoshioka Y, Shimomura M, Saito K, Ishii H, Doki Y, Eguchi H, Nakatsura T, Itoi T, Kuroda M, Mori M, Ochiya T.
    Cancer Sci; 2022 Oct 03; 113(10):3498-3509. PubMed ID: 35848896
    [Abstract] [Full Text] [Related]

  • 11. Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer.
    Dittmar RL, Liu S, Tai MC, Rajapakshe K, Huang Y, Longton G, DeCapite C, Hurd MW, Paris PL, Kirkwood KS, Coarfa C, Maitra A, Brand RE, Killary AM, Sen S.
    Cancer Prev Res (Phila); 2021 Jul 03; 14(7):729-740. PubMed ID: 33893071
    [Abstract] [Full Text] [Related]

  • 12. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia.
    Vila-Navarro E, Duran-Sanchon S, Vila-Casadesús M, Moreira L, Ginès À, Cuatrecasas M, Lozano JJ, Bujanda L, Castells A, Gironella M.
    Clin Transl Gastroenterol; 2019 Apr 03; 10(4):e00029. PubMed ID: 31009404
    [Abstract] [Full Text] [Related]

  • 13. An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study.
    Nakamura K, Zhu Z, Roy S, Jun E, Han H, Munoz RM, Nishiwada S, Sharma G, Cridebring D, Zenhausern F, Kim S, Roe DJ, Darabi S, Han IW, Evans DB, Yamada S, Demeure MJ, Becerra C, Celinski SA, Borazanci E, Tsai S, Kodera Y, Park JO, Bolton JS, Wang X, Kim SC, Von Hoff D, Goel A.
    Gastroenterology; 2022 Nov 03; 163(5):1252-1266.e2. PubMed ID: 35850192
    [Abstract] [Full Text] [Related]

  • 14. Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma.
    Nakamura S, Sadakari Y, Ohtsuka T, Okayama T, Nakashima Y, Gotoh Y, Saeki K, Mori Y, Nakata K, Miyasaka Y, Onishi H, Oda Y, Goggins M, Nakamura M.
    Ann Surg Oncol; 2019 Jul 03; 26(7):2104-2111. PubMed ID: 30820789
    [Abstract] [Full Text] [Related]

  • 15. Circular RNA expression profiles in extracellular vesicles from the plasma of patients with pancreatic ductal adenocarcinoma.
    Li Q, Geng S, Yuan H, Li Y, Zhang S, Pu L, Ge J, Niu X, Li Y, Jiang H.
    FEBS Open Bio; 2019 Dec 03; 9(12):2052-2062. PubMed ID: 31605569
    [Abstract] [Full Text] [Related]

  • 16. Exosomal miRNA Biomarker Panel for Pancreatic Ductal Adenocarcinoma Detection in Patient Plasma: A Pilot Study.
    Makler A, Asghar W.
    Int J Mol Sci; 2023 Mar 07; 24(6):. PubMed ID: 36982154
    [Abstract] [Full Text] [Related]

  • 17. CD63-positive extracellular vesicles are potential diagnostic biomarkers of pancreatic ductal adenocarcinoma.
    Odaka H, Hiemori K, Shimoda A, Akiyoshi K, Tateno H.
    BMC Gastroenterol; 2022 Mar 28; 22(1):153. PubMed ID: 35350978
    [Abstract] [Full Text] [Related]

  • 18. miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Alemar B, Izetti P, Gregório C, Macedo GS, Castro MA, Osvaldt AB, Matte U, Ashton-Prolla P.
    Pancreas; 2016 Jan 28; 45(1):84-92. PubMed ID: 26262588
    [Abstract] [Full Text] [Related]

  • 19. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
    Munding JB, Adai AT, Maghnouj A, Urbanik A, Zöllner H, Liffers ST, Chromik AM, Uhl W, Szafranska-Schwarzbach AE, Tannapfel A, Hahn SA.
    Int J Cancer; 2012 Jul 15; 131(2):E86-95. PubMed ID: 21953293
    [Abstract] [Full Text] [Related]

  • 20. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
    Xue Y, Abou Tayoun AN, Abo KM, Pipas JM, Gordon SR, Gardner TB, Barth RJ, Suriawinata AA, Tsongalis GJ.
    Cancer Genet; 2013 Jun 15; 206(6):217-21. PubMed ID: 23933230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.